GSTM1 and TNF-α gene polymorphisms and relations between blood lead and inflammatory markers in a non-occupational population

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 629, Issue 1, 2007, Pages 32-39

  Kim, Jin Hee ^a   Lee, Kwan Hee ^b   Yoo, Dong Ho ^a   Kang, Daehee ^a   Cho, Soo Hun ^a,c   Hong, Yun Chul ^a,c  

^a Seoul National University College of Medicine   (South Korea)

^b Inha University Hospital   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

GSTM1; Inflammatory marker; Lead; Polymorphism; TNF

Indexed keywords

GLUTATHIONE TRANSFERASE M1; INTERLEUKIN 6; LEAD; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE LOSS; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN EXPERIMENT; INFLAMMATION; LEAD BLOOD LEVEL; LEUKOCYTE COUNT; MALE; NORMAL HUMAN; POLYMERASE CHAIN REACTION; POPULATION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; UNIVERSITY STUDENT;

ADULT; ALLELES; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUTATHIONE TRANSFERASE; HUMANS; INFLAMMATION; INTERLEUKIN-6; LEAD; LEUKOCYTE COUNT; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; STUDENTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33947597681     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2007.01.004     Document Type: Article

References (43)

1. Kaysen G.A. Inflammation: cause of vascular disease and malnutrition in dialysis patients. Semin. Nephrol. 24 (2004) 431-436
2. Balkwill F., and Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 357 (2001) 539-545
3. Busse W.W., and Lemanske Jr. R.F. Asthma. N. Engl. J. Med. 344 (2001) 350-362
4. Coussens L.M., and Werb Z. Inflammation and cancer. Nature 420 (2002) 860-867
5. Villanueva M.B., Koizumi S., and Jonai H. Cytokine production by human peripheral blood mononuclear cells after exposure to heavy metals. J. Health Sci. 46 (2000) 358-362
6. Hsiao C.Y., Wu H.D., Lai J.S., and Kuo H.W. A longitudinal study of the effects of long-term exposure to lead among lead battery factory workers in Taiwan (1989-1999). Sci. Total Environ. 279 (2001) 151-158
7. Saxena G., and Flora S.J. Lead-induced oxidative stress and hematological alterations and their response to combined administration of calcium disodium EDTA with a thiol chelator in rats. J. Biochem. Mol. Toxicol. 18 (2004) 221-233
8. Basaran N., and Undeger U. Effects of lead on immune parameters in occupationally exposed workers. Am. J. Ind. Med. 38 (2000) 349-354
9. Yucesoy B., Turhan A., Ure M., Imir T., and Karakaya A. Effects of occupational lead and cadmium exposure on some immunoregulatory cytokine levels in man. Toxicology 123 (1997) 143-147
10. Mishra K.P., Singh V.K., Rani R., Yadav V.S., Chandran V., Srivastava S.P., and Seth P.K. Effect of lead exposure on the immune response of some occupationally exposed individuals. Toxicology 188 (2003) 251-259
11. Komori A., Yatsunami J., Suganuma M., Okabe S., Abe S., Sakai A., Sasaki K., and Fujiki H. Tumor necrosis factor acts as a tumor promoter in BALB/3T3 cell transformation. Cancer Res. 53 (1993) 1982-1985
12. Hutchins D., and Steel C.M. Regulation of ICAM-1 (CD54) expression in human breast cancer cell lines by interleukin 6 and fibroblast-derived factors. Int. J. Cancer 58 (1994) 80-84
13. Barton B.E. The biological effects of interleukin 6. Med. Res. Rev. 1 (1996) 87-109
14. Schmidt M.I., Duncan B.B., Sharrett A.R., Lindberg G., Savage P.J., Offenbacher S., Azambuja M.I., Tracy R.P., and Heiss G. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet 353 (1999) 1649-1652
15. Knight B., Yeoh G.C., Husk K.L., Ly T., Abraham L.J., Yu C., Rhim J.A., and Fausto N. Impaired preneoplastic changes and liver tumor formation in tumor necrosis factor receptor type 1 knockout mice. J. Exp. Med. 192 (2000) 1809-1818
16. Szlosarek P.W., and Balkwill F.R. Tumor necrosis factor α: a potential target for the therapy of solid tumors. Lancet Oncol. 4 (2003) 565-573
17. Pikarsky E., Porat R.M., Stein I., Abramovitch R., Amit S., Kasem S., Gutkovich-Pyest E., Urieli-Shoval S., Galun E., and Ben-Neriah Y. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 431 (2004) 461-466
18. Kim R., Rotnitsky A., Sparrow D., Weiss S., Wager C., and Hu H. A longitudinal study of low-level lead exposure and impairment of renal function. The normative aging study. JAMA 275 (1996) 1177-1181
19. Osman K., Zejda J.E., Schutz A., Mielzynska D., Elinder C.G., and Vahter M. Exposure to lead and other metals in children from Katowice district, Poland. Int. Arch. Occup. Environ. Health 71 (1998) 180-186
20. Brasch-Andersen C., Christiansen L., Tan Q., Haagerup A., Vestbo J., and Kruse T.A. Possible gene dosage effect of glutathione-S-transferases on atopic asthma: using real-time PCR for quantification of GSTM1 and GSTT1 gene copy numbers. Hum. Mutat. 24 (2004) 208-214
21. Dwivedi R.S. Lead exposure alters the drug metabolic activity and the homeostasis of essential metal ions in the lenticular system of the rat. Environ. Pollut. 94 (1996) 61-66
22. Daggett D.A., Oberley T.D., Nelson S.A., Wright L.S., Kornguth S.E., and Siegel F.L. Effects of lead on rat kidney and liver: GST expression and oxidative stress. Toxicology 128 (1998) 191-206
23. Mohrenweiser H.W., and Jones I.M. Variation in DNA repair is a factor in cancer susceptibility: a paradigm for the promises and perils of individual and population risk estimation?. Mutat. Res. 400 (1998) 15-24
24. Kelada S.N., Kardia S.L., Walker A.H., Wein A.J., Malkowicz S.B., and Rebbeck T.R. The glutathione S-transferase-mu and -theta genotypes in the etiology of prostate cancer: genotype-environment interactions with smoking. Cancer Epidemiol. Biomark. Prev. 9 (2000) 1329-1334
25. Shields P., and Harris C. Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. J. Clin. Oncol. 18 (2000) 2309-2315
26. Miller M.C., Mohrenweiser H.W., and Bell D.A. Genetic variability in susceptibility and response to toxicants. Toxicol. Lett. 120 (2001) 269-280
27. Tsukino H., Nakao H., Kuroda Y., Imai H., Inatomi H., Osada Y., and Katoh T. Glutathione S-transferase (GST) M1, T1 and N-acetyltransferase 2 (NAT2) polymorphisms and urothelial cancer risk with tobacco smoking. Eur. J. Cancer Prev. 13 (2004) 509-514
28. Palli D., Saieva C., Gemma S., Masala G., Gomez-Miguel M.J., Luzzi I., D'Errico M., Matullo G., Ozzola G., Manetti R., Nesi G., Sera F., Zanna I., Dogliotti E., and Testai E. GSTT1 and GSTM1 gene polymorphisms and gastric cancer in a high-risk Italian population. Int. J. Cancer 15 (2005) 284-289
29. Wenzlaff A.S., Cote M.L., Bock C.H., Land S.J., and Schwartz A.G. GSTM1, GSTT1 and GSTP1 polymorphisms, environmental tobacco smoke exposure and risk of lung cancer among never smokers: a population-based study. Carcinogenesis 26 (2005) 395-401
30. Hsieh Y.Y., Chang C.C., Tsai F.J., Lin C.C., Yeh L.S., and Tsai C.H. Tumor necrosis factor-α-308 promoter and p53 codon 72 gene polymorphisms in women with leiomyomas. Fertil. Steril. 82 (2004) 1177-1181
31. Perez C., Gonzalez F.E., Pavez V., Araya A.V., Aguirre A., Cruzat A., Contreras-Levicoy J., Dotte A., Aravena O., Salazar L., Catalan D., Cuenca J., Ferreira A., Schiattino I., and Aguillon J.C. The -308 polymorphism in the promoter region of the tumor necrosis factor-alpha (TNF-alpha) gene and ex vivo lipopolysaccharide-induced TNF-alpha expression in patients with aggressive periodontitis and/or type 1 diabetes mellitus. Eur. Cytokine Netw. 15 (2004) 364-370
32. Ho S.Y., Wang Y.J., Chen H.L., Chen C.H., Chang C.J., Wang P.J., Chen H.H., and Guo H.R. Increased risk of developing hepatocellular carcinoma associated with carriage of the TNF2 allele of the -308 tumor necrosis factor-alpha promoter gene. Cancer Causes Control 15 (2004) 657-663
33. Bell D.A., Taylor J.A., Paulson D.F., Robertson C.N., Mohler J.L., and Lucier G.W. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J. Natl. Cancer Inst. 85 (1993) 1159-1164
34. Allen R.A., Lee E.M., Roberts D.H., Park B.K., and Pirmohamed M. Polymorphisms in the TNF-alpha and TNF-receptor genes in patients with coronary artery disease. Eur. J. Clin. Invest. 31 (2001) 843-851
35. Walczak-Drzewiecka A., Wyczolkowska J., and Dastych J. Environmentally relevant metal and transition metal ions enhance FcεRI-mediated mast cell activation. Environ. Health Perspect. 111 (2003) 708-713
36. Bernier J., Brousseau P., Krzystyniak K., Tryphonas H., and Fournier M. Immunotoxicity of heavy metals in relation to Great Lakes. Environ. Health Perspect. 103 (1995) 23-34
37. Aggarwal B.B. Tumour necrosis factors receptor associated signalling molecules and their role in activation of apoptosis, JNK and NF-kappaB. Ann. Rheum. Dis. 59 (2000) i6-i16
38. Morgan G.J., Adamson P.J., Mensah F.K., Spink C.F., Law G.R., Keen L.J., Roman E., Davies F.E., Rollinson S., Child J.A., and Bidwell J.L. Haplotypes in the tumour necrosis factor region and myeloma. Br. J. Haematol. 129 (2005) 358-365
39. Schafer J.H., Glass T.A., Bressler J., Todd A.C., and Schwartz B.S. Blood lead is a predictor of homocysteine levels in a population-based study of older adults. Environ. Health Perspect. 113 (2005) 31-35
40. Institoris L., Siroki O., and Undeger U. Immunotoxicological examination of repeated dose combined exposure by dimethoate and two heavy metals in rats. Hum. Exp. Toxicol. 19 (1999) 88-94
41. Bachen E.A., Manuck S.B., Marsland A.L., Cohen S., Malkoff S.B., Muldoon M.F., and Rabin B.S. Lymphocyte subset and cellular immune responses to a brief experimental stressor. Psychosom. Med. 54 (1992) 673-679
42. Uthgenannt D., Schoolmann D., Pietrowsky R., Fehm H.L., and Born J. Effects of sleep on the production of cytokines in humans. Psychosom. Med. 57 (1995) 97-104
43. Esterling B.A., Kiecolt-Glaser J.K., and Glaser R. Psychosocial modulation of cytokine-induced natural killer cell activity in older adults. Psychosom. Med. 58 (1996) 264-272